What is the dose equivalence between losartan and valsartan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Losartan-Valsartan Dose Equivalence

Based on guideline-recommended target doses for heart failure, losartan 100 mg once daily is approximately equivalent to valsartan 160 mg twice daily (320 mg total daily dose). 1, 2, 3, 4

Guideline-Based Dose Equivalence

The most authoritative dose equivalence comes from major cardiovascular guidelines that specify target doses proven effective in clinical trials:

Target Doses from Guidelines

For Heart Failure with Reduced Ejection Fraction (HFrEF):

  • Losartan: 100 mg once daily (total daily: 100 mg) 1, 2, 3
  • Valsartan: 160 mg twice daily (total daily: 320 mg) 1, 2, 3, 4

This represents an approximate 1:3.2 ratio (losartan:valsartan) when comparing total daily doses at guideline-recommended targets.

For Hypertension:

  • Losartan: 50-100 mg once daily 5
  • Valsartan: 80-320 mg once daily 5

The FDA-approved maximum dose is 100 mg for losartan, though ACC/AHA guidelines note that 150 mg has been studied and may be more effective 1, 6.

Clinical Trial Evidence Supporting Equivalence

Direct Comparative Studies

Multiple head-to-head trials have compared these agents at their commonly prescribed doses:

  • Losartan 50 mg vs. Valsartan 80 mg: These doses produced similar blood pressure reductions and were considered clinically equivalent 7, 8, 9
  • Losartan 100 mg vs. Valsartan 160 mg: At doubled doses, both agents showed comparable efficacy 7

However, valsartan 160 mg demonstrated a significantly higher responder rate (62%) compared to losartan 100 mg (55%) in one trial 9, suggesting valsartan may have slightly greater efficacy at these dose levels.

Receptor Blockade Studies

Pharmacodynamic studies measuring AT1-receptor blockade reveal important dose-response relationships:

  • Losartan 50 mg and valsartan 80 mg produced comparable receptor blockade 10
  • Valsartan 160-320 mg achieved receptor blockade similar to irbesartan 150 mg and candesartan 8 mg 10
  • The differences between ARBs are primarily explained by dosing rather than intrinsic drug properties 10

Practical Conversion Algorithm

When switching from losartan to valsartan:

  1. If patient is on losartan 50 mg once daily → Switch to valsartan 80-160 mg once daily (or 80 mg twice daily)

  2. If patient is on losartan 100 mg once daily → Switch to valsartan 160 mg twice daily (320 mg total daily)

  3. For heart failure patients: Always target the guideline-recommended doses (losartan 100 mg daily or valsartan 320 mg daily) unless not tolerated 1, 2, 3

When switching from valsartan to losartan:

  1. If patient is on valsartan 80 mg once or twice daily → Switch to losartan 50 mg once daily

  2. If patient is on valsartan 160 mg twice daily (320 mg total) → Switch to losartan 100 mg once daily

Important Clinical Considerations

Dosing Frequency Matters

  • Losartan: Once-daily dosing is standard
  • Valsartan: Twice-daily dosing (160 mg BID) provides superior 24-hour blood pressure control compared to once-daily dosing at the same total dose 1, 2, 3

Uric Acid Effects

Losartan uniquely lowers serum uric acid (average decrease 0.4 mg/dL), while valsartan does not 7, 8. This may be clinically relevant in patients with gout or hyperuricemia.

Bioavailability Differences

The oral suspension formulation of valsartan has 60% higher systemic exposure (AUC) compared to tablets 11. Do not substitute tablet and suspension forms on a milligram-per-milligram basis.

Titration Strategy

Both drugs should be initiated at low doses and titrated to target doses every 1-2 weeks as tolerated 2, 3. The target doses from clinical trials provide the greatest mortality and morbidity benefit in heart failure 1, 2, 3.

Common Pitfalls to Avoid

  1. Do not assume 1:1 equivalence – Valsartan requires approximately 3 times the dose of losartan for equivalent effect
  2. Do not use losartan 50 mg as equivalent to valsartan 160 mg – These are not equivalent doses
  3. Do not forget to adjust for twice-daily dosing when prescribing valsartan for heart failure
  4. Do not stop at lower doses if tolerated – Target doses provide superior outcomes 1, 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.